$2 Million Jury Verdict for Accutane Plaintiff

A New Jersey jury awarded Gillian Gaghan $2 million after it determined that the acne medication Accutane was the cause of her Inflammatory Bowel Disease, which has left her with a lifetime of serious health problems. Hoffman La Roche, the defendant drug manufacturer, claimed the drug was not the cause of her injuries, that its warnings were adequate and that a lack of warnings was not responsible for her taking the medication. Instead, they proffered cigarette smoking and birth control pills as the cause of her disease. Obviously the jury did not agree with that argument. Critical to her courtroom victory was the determination that Gaghan, 34, would not have taken Accutane had she been adequately warned of the drug's gastrointestinal side effects.

This makes it six consecutive juries that have found the manufactuer's label inadequate to warn of the risk of developing Crohn's disease or Ulcerative Colitis after using Accutane.

Accutane Litigation